Suwandhi, P, Dharmarajan, TS. Scabies in the nursing home. Current Infectious Disease Reports
2015; 17: 453.
Hewitt, KA, Nalabanda, A, Cassell, JA. Scabies outbreaks in residential care homes: factors associated with late recognition, burden and impact. A mixed methods study in England. Epidemiology and Infection
2015; 143: 1542–1551.
Hengge, UR, et al.
Scabies: a ubiquitous neglected skin disease. Lancet Infectious Diseases
2006; 6: 769–779.
Fuller, LC. Epidemiology of scabies. Current opinion in Infectious Diseases
2013; 26: 123–126.
Green, M. Epidemiology of scabies. Epidemiological Reviews
1989; 11: 126–150.
Walton, SF. The immunology of susceptibility and resistance to scabies
2010; 32: 532–540.
Vos, T, et al.
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet
2015; 386: 743–800.
Mounsey, K, et al. Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forward. Epidemiology and Infection. Published online: 28 March 2016. doi:10.1017/S0950268816000443.
Hay, RJ, et al.
The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. Journal of Investigative Dermatology
2013; 134: 1–8.
Bouvresse, S, Chosidow, O. Scabies in healthcare settings. Current Opinion in Infectious Diseases
2010; 23: 111–118.
Wilson, MG, Philpott, CD, Breer, WA. Atypical presentation of scabies among nursing home residents. Journal of Gerontology: Medical Sciences
2001; 56: M424–M427.
Chosidow, O. Scabies and pediculosis. Lancet
2000; 355: 819–826.
Lay, CJ, et al.
Risk factors for delayed diagnosis of scabies in hospitalized patients from long-term care facilities. Journal of Clinical Medicine Research
2011; 3: 72–77.
Hawker, J, et al.
Communicable Disease Control Hand-book, 2nd edn.
New Jersey: Wiley-Blackwell, 2005, pp. 200–203.
Lassa, S, Campbell, MJ, Bennett, CE. Epidemiology of scabies prevalence in the U.K. from general practice records. British Journal of Dermatology
2011; 164: 1329–1334.
Barkwell, R, Shields, S. Deaths associated with ivermectin treatment of scabies. Lancet
1997; 349: 1144–1145.
National Institute for Health Care Excellence (NICE). Clinical knowledge summaries. Scabies, 2011 (http://cks.nice.org.uk/scabies). Accessed 26 August 2015.
Fitzgerald, D, Grainger, RJ, Reid, A. Interventions for preventing the spread of infestation in close contacts of people with scabies. Cochrane Database of Systematic Reviews
2014; 2: CD009943.
Scott, GR, Chosidow, O. European guideline for the management of scabies, 2010. International Journal of STD & AIDS
2011; 22: 301–303.
British Association for Sexual Health and HIV (BASHH). United Kingdom national guideline on the management of scabies infestation 2007, 2007. (www.bashh.org/documents/27/27.pdf). Accessed 26 January 2016.
Ladbury, G, et al.
An outbreak of scabies in multiple linked healthcare settings in The Netherlands. Infection Control & Hospital Epidemiology
2012; 33: 1047–1050.
Wolf, R, Davidovici, B. Treatment of scabies and pediculosis: facts and controversies. Clinical Dermatology
2010; 28: 511–518.
Strong, M, Johnstone, P. Interventions for treating scabies. Cochrane Database of Systematic Reviews
2007; 3: CD000320.
Coyne, PE, Addiss, DG. Deaths associated with ivermectin for scabies.
1997; 350: 215–216.
Bockarie, MJ, et al.
Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea. Acta Tropica
2000; 75: 127–30.
Heukelbach, J, Feldmeier, H. Scabies. Lancet
Usha, V, Gopalakrishnan Nair, T V. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology
2000; 42: 236–240.
Tsutsumi, M, Nishiura, H, Kobayashi, T. Dementia-specific risks of scabies: retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989–90
BMC Infectious Diseases
2005; 5: 85.